1. Proteomic Level Changes on Treatment in MCF-7/DDP Breast Cancer Drug- Resistant Cells
   Gongshen Jin et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
2. High expression of RRM2 mediated by non-coding RNAs correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma
   Guochao Mao et al, 2022, Frontiers in Medicine CrossRef
3. A 9‐gene prognostic signature for kidney renal clear cell carcinoma overall survival based on co‐expression and regression analyses
   Wenwen Zhu et al, 2023, Chemical Biology & Drug Design CrossRef
4. Identification of Four Pathological Stage-Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis
   Dengyong Xu et al, 2020, BioMed Research International CrossRef
5. Anti-angiogenic Drug Resistance: Roles and Targeting of Non-coding RNAs (microRNAs and long non-coding RNAs)
   Masoumeh Eliyasi Dashtaki et al, 2023, Current Molecular Pharmacology CrossRef
6. Improvement of variables interpretability in kernel PCA
   Mitja Briscik et al, 2023, BMC Bioinformatics CrossRef
7. Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC)
   María Armesto et al, 2021, Cancers CrossRef
8. microRNA‐99a‐5p induces cellular senescence in gemcitabine‐resistant bladder cancer by targeting SMARCD1
   Motoki Tamai et al, 2022, Molecular Oncology CrossRef
9. MetastamiRs in Renal Cell Carcinoma: An Overview of MicroRNA Implicated in Metastatic Kidney Cancer
   Jonathan Xu et al, 2022, Urologic Cancers CrossRef
10. Advances in Renal Cell Carcinoma Drug Resistance Models
    Yien Xiang et al, 2022, Frontiers in Oncology CrossRef
11. The Ambivalent Role of miRNAs in Carcinogenesis: Involvement in Renal Cell Carcinoma and Their Clinical Applications
    Federica Spadaccino et al, 2021, Pharmaceuticals CrossRef
12. Still no Rest for the Reductases: Ribonucleotide Reductase (RNR) Structure and Function: An Update
    Marcus J. C. Long et al, 2022, Macromolecular Protein Complexes IV CrossRef
13. A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming
    Lorena Incorvaia et al, 2020, Cancers CrossRef
14. Epigenetic Alterations in Renal Cell Cancer With TKIs Resistance: From Mechanisms to Clinical Applications
    Qinhan Li et al, 2021, Frontiers in Genetics CrossRef
15. Identification of Novel Genes and Associated Drugs in Advanced Clear Cell Renal Cell Carcinoma by Bioinformatic Methods
    Meiqi Lu et al, 2022, The Tohoku Journal of Experimental Medicine CrossRef
16. Identifying the molecular mechanisms of sepsis-associated acute kidney injury and predicting potential drugs
    Guangfeng Guo et al, 2022, Frontiers in Genetics CrossRef